Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein

Journal of Medicinal Chemistry

Volumn 53, Issue 14, 2010, Pages 5144-5154

  Margiotta, Nicola ^a   Denora, Nunzio ^a   Ostuni, Rosa ^a   Laquintana, Valentino ^a   Anderson, Amy ^b   Johnson, Steven W ^b   Trapani, Giuseppe ^a   Natile, Giovanni ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMD 0473; BENZODIAZEPINE RECEPTOR; CARRIER PROTEIN; CISPLATIN; PICOPLATIN; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RECEPTOR BINDING; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; RAT; RECEPTOR AFFINITY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CEREBRAL CORTEX; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIGANDS; ORGANOPLATINUM COMPOUNDS; RADIOLIGAND ASSAY; RATS; RECEPTORS, GABA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77954717300     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100429r     Document Type: Article

References (44)

1. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Lippert, B., Ed.; Verlag Helvetica Chimica Acta: Zurich, Switzerland, 2000; 563 pp.
2. Jakupec, M. A.; Galanski, M.; Arion, V. B.; Hartinger, C. G.; Keppler, B. K. Antitumour metal compounds: more than theme and variations Dalton Trans. 2008, 183-194
3. Fuertes, M. A.; Alonso, C.; Pérez, J. M. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance Chem. Rev. 2003, 103, 645-662
4. Johnson, S. W.; Stevenson, J. P.; O'Dwyer, P. J. Cisplatin and Its Analogues. In Cancer: Principles and Practice of Oncology, 6 th ed.; DeVita, V. T., Jr.; Hellman, S.; Rosenberg, S. A., Eds.; J. B. Lippincott Company: Philadelphia, PA, 2001; pp 376 - 388.
5. Cleare, M. J.; Hoeschele, J. D. Antitumor platinum compounds. Relation between structure and activity Platinum Met. Rev. 1973, 17, 2-13
6. Cleare, M. J.; Hoeschele, J. D. Antitumor activity of group VIII transition metal complexes. I. Platinum(II) complexes Bioinorg. Chem. 1973, 2, 187-210
7. Wong, E.; Giandomenico, C. M. Current status of platinum-based antitumor drugs Chem. Rev. 1999, 99, 2451-2466
8. Natile, G.; Coluccia, M. Metal Complexes in Tumor Diagnosis and as Anticancer Agents; Sigel, A.; Sigel, H., Eds.; Metal Ions in Biological Systems, Vol. 42; Marcel Dekker: New York, 2004; pp 209 - 250.
9. Natile, G.; Coluccia, M. Current status of trans-platinum compounds in cancer therapy Coord. Chem. Rev. 2001, 216-217, 383-410
10. Kelland, L. The resurgence of platinum-based cancer chemotherapy Nat. Rev. Cancer 2007, 7, 573-584
11. Reedijk, J. Platinum anticancer coordination compounds: study of DNA binding inspires new drug design Eur. J. Inorg. Chem. 2009, 1303-1312
12. Arnesano, F.; Natile, G. Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA Coord. Chem. Rev. 2009, 253, 2070-2081
13. Hall, M. D.; Mellor, H. R.; Callaghan, R.; Hambley, T. W. Basis for design and development of platinum(IV) anticancer complexes J. Med. Chem. 2007, 50, 3403-3411
14. Wang, D.; Lippard, S. J. Cellular processing of platinum anticancer drugs Nat. Rev. Drug Discovery 2005, 4, 307-320
15. Galanski, M.; Jakupec, M. A.; Keppler, B. K. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches Curr. Med. Chem. 2005, 12, 2075-2094
16. Margiotta, N.; Ostuni, R.; Ranaldo, R.; Denora, N.; Laquintana, V.; Trapani, G.; Liso, G.; Natile, G. Synthesis and characterization of a platinum(II) tethered to a ligand of the peripheral benzodiazepine receptor J. Med. Chem. 2007, 50, 1019-1027
17. Papadopoulos, V.; Baraldi, M.; Guilarte, T. R.; Knudsen, T. B.; Lacapére, J.-J.; Limdermann, P.; Norenberg, M. D.; Nutt, D.; Weizman, A.; Zhang, M.-R.; Gavish, M. Translocator protein (18 kD): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol. Sci. 2006, 27, 402-409
18. Galiegue, S.; Tinel, N.; Casellas, P. The peripheral benzodiazepine receptors: a promising therapeutic drug target Curr. Med. Chem. 2003, 10, 1563-1572
19. Maaser, K.; Grabowski, P.; Surter, A. P.; Hopfner, M.; Foss, H. D.; Stein, H.; Berger, G.; Gavish, M.; Zeitz, M.; Scherübl, A. P. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer Clin. Cancer Res. 2002, 8, 3205-3209
20. Miettinen, H.; Kononen, J.; Haapasalo, H.; Helen, P.; Sallinen, P.; Harjuntausta, T.; Helin, H.; Alho, H. Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation Cancer Res. 1995, 55, 2691-2695
21. Veenman, L.; Levin, E.; Weisinger, G.; Leschiner, S.; Spanier, I.; Snyder, S. H.; Weizman, A.; Gavish, M. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines Biochem. Pharmacol. 2004, 68, 689-698
22. Cappelli, A.; Mohr, G. P.; Gallelli, A.; Giuliani, G.; Anzini, M.; Vomero, S.; Fresta, M.; Porcu, P.; Maciocco, E.; Concas, A.; Biggio, G.; Donati, A. Structure-activity relationships in carboxamide derivatives based on the targeted delivery of radionuclides and boron atoms by means of peripheral benzodiazepine receptor ligands J. Med. Chem. 2003, 46, 3568-3571
23. Guo, Z.; Gallo, J. M. Selective protection of 2′,2′- difluorodeoxycytidine (gemcitabine) J. Org. Chem. 1999, 64, 8319-8322
24. Guo, P.; Ma, J.; Guo, Z.; Adams, A. L.; Gallo, J. M. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model Cancer Chemother. Pharmacol. 2001, 48, 169-176
25. Decaudin, D.; Castedo, M.; Nemati, F.; Beurdeley-Thomas, A.; De Pinieux, G.; Caron, A.; Pouillart, P.; Wijdenes, J.; Rouillard, D.; Kroemer, G.; Poupon, M. F. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo Cancer Res. 2002, 62, 1388-1393
26. Oudard, S.; Miccoli, L.; Dutrillaux, B.; Poupon, M. F. Targeting the gene of glucose metabolism for the treatment of advanced gliomas Bull. Cancer 1998, 85, 622-627
27. Trapani, G.; Franco, M.; Ricciardi, L.; Latrofa, A.; Genchi, G.; Sanna, E.; Tuveri, F.; Cagetti, E.; Biggio, G.; Liso, G. Synthesis and binding affinity of 2-phenyl-imidazo[1,2-a]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new series of high-affinity and selective ligands for the peripheral type J. Med. Chem. 1997, 40, 3109-3118
28. Trapani, G.; Franco, M.; Latrofa, A.; Ricciardi, L.; Carotti, A.; Serra, M.; Sanna, E.; Biggio, G.; Liso, G. Novel 2-phenyl-imidazo[1,2-a]pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors. synthesis, binding affinity, and in vivo studies J. Med. Chem. 1999, 42, 3934-3941
29. Trapani, G.; Laquintana, V.; Denora, N.; Trapani, A.; Lopedota, A.; Latrofa, A.; Franco, M.; Serra, M.; Pisu, M. G.; Floris, I.; Sanna, E.; Biggio, G.; Liso, G. Structure-activity relationships and effects on the neurosteroids synthesis in a series of 2-phenyl-imidazo[1,2-a]pyridine-acetamide peripheral benzodiazepine receptors ligands J. Med. Chem. 2005, 48, 292-305
30. Gibson, D.; Mansur, N.; Gean, K. F. Preparation, characterization, and antitumor properties of cis-dichlorodiammineplatinum complexes linked to anthraquinones through position number 2 J. Inorg. Biochem. 1995, 58, 79-88
31. Romaniewska, A.; Jasztold-Howorko, R.; Regiec, A.; Lis, T.; Kuduk-Jaworska, J. Synthesis, structure and characterization of new olivacine derivatives and their platinum(II) complexes Eur. J. Inorg. Chem. 2003, 4043-4054
32. Bentzion, D.; Lipatov, O.; Polyakov, I.; MacKintosh, R.; Eckardt, J.; Breitz, H. A phase II study of picoplatin (pico) as second-line therapy for patients (pts) with small cell lung cancer (SCLC) who have resistant or refractory disease or have relapsed within 180 days of completing first-line, platinum (plat)-containing chemotherapy J. Clin. Oncol. 2007, 25 (18S, June 20 Suppl.) 7722; SCO Annual Meeting Proceedings Part I
33. Hardwick, M.; Cavalli, L. R.; Barlow, K. D.; Haddad, B. R.; Papadopoulos, V. Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells Cancer Genet. Cytogenet. 2002, 139, 48-51
34. Berners-Price, S. J.; Ronconi, L.; Sadler, P. J. Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy Prog. Nucl. Magn. Reson. Spectrosc. 2006, 49, 65-98
35. 2, where Ypy = pyridine derivative and X = Cl and I Inorg. Chim. Acta 1999, 295, 25-38
36. 2 and their aqueous products Inorg. Chim. Acta 2005, 358, 2040-2056
37. II chelate complex incorporating the cis -1,4-diaminocyclohexane carrier ligand Biochem. Pharmacol. 2010, 79, 552-564
38. Kelland, L. R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P. M.; Valentini, M. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro- cyclohexylamine platinum(IV): an orally active platinum drug Cancer Res. 1993, 53, 2581-2586
39. Laquintana, V.; Denora, N.; Musacchio, T.; Lasorsa, M.; Latrofa, A.; Trapani, G. Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents J. Controlled Release 2009, 137, 185-195
40. Holford, J.; Sharp, S. Y.; Murrer, B. A.; Abrams, M.; Kelland, L. R. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473 Br. J. Cancer. 1998, 77, 366
41. Hwang, T. -L.; Shaka, A. J. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients J. Magn. Reson., Ser. A 1995, 112, 275-279
42. 2] Indian J. Chem. 1970, 8, 193-194
43. Oksanen, A; Leskelä, M. Synthesis of ammonium trichloromonoammineplatinate(II) improved through control of temperature Acta Chem. Scand. 1994, 48, 485-489
44. Hansen, M.; Nielsen, S.; Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill Immunol. Methods 1989, 119, 203-210